Furthermore, our results indicate that KCNJ2 may influence key pathways related to proliferation, migration, invasion, apoptosis, and glucose metabolism in ccRCC cells, thereby contributing to the aggressive phenotype of this cancer. This evidence concerns the gene KCNJ2 and nonpapillary renal cell carcinoma.